Home › Targets › p53 Y220C

p53 Y220C (1 companies · 7 programs)

Companies with an active program directed at p53 Y220C.

PMV Pharmaceuticals, Inc. PMVP

rezatapopt — Ovarian Cancer Phase 2
rezatapopt — Non-Small Cell Lung Cancer Phase 2
rezatapopt — Breast Cancer Phase 2
rezatapopt — Endometrial Cancer Phase 2
rezatapopt — Colorectal Cancer Phase 2
rezatapopt — Pancreatic Cancer Phase 2
rezatapopt — Solid Tumors Phase 2